Absence of RBM expression as a marker of intratubular (in situ) germ cell neoplasia of the testis.

RBM (RNA-binding motif) protein is a marker of male germ cells. This protein is encoded by the Azoospermia factor region-b (AZF-b) of the human Y chromosome and is expressed exclusively in the male germ cell line, that is, spermatogonia, spermatocytes, and round spermatids. The authors analyzed the expression of the RBM gene in germ cell tumors and in the seminiferous tubules in the vicinity of these tumors to identify the presence of IGCN. Sections from testicular germ cell tumors of 21 patients were stained with anti-RBM antibody by using an immunohistochemical method. Distal tubules showing spermatogenesis were immunopositive for RBM protein. All of the germ cell tumors studied were completely immunonegative for RBM. Defined areas of IGCN also showed an absence of RBM expression. Tubules with spermatocyte-like cells, which were expected to express RBM, did not express this protein. This result enabled the identification of tubules as being IGCN. RBM is a novel marker consistently expressed in normal male germ cells but not in malignant germ cell tumors or IGCN. Thus, the absence of RBM expression in germ cells provides a new diagnostic tool of preinvasive malignancy of the testis.

[1]  Henrik Møller,et al.  Risk of testicular cancer in subfertile men: case-control study , 1999, BMJ.

[2]  L. Veeck,et al.  AZFb deletions predict the absence of spermatozoa with testicular sperm extraction: preliminary report of a prognostic genetic test. , 1998, Human reproduction.

[3]  I. Eperon,et al.  Dynamic changes in the subnuclear organisation of pre-mRNA splicing proteins and RBM during human germ cell development. , 1998, Journal of cell science.

[4]  A. Edelmann,et al.  DAZ (Deleted in AZoospermia) genes encode proteins located in human late spermatids and in sperm tails. , 1998, Human reproduction.

[5]  D. Page,et al.  Functional coherence of the human Y chromosome. , 1997, Science.

[6]  P. Vogt,et al.  Expression of RBM in the nuclei of human germ cells is dependent on a critical region of the Y chromosome long arm. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  N. Skakkebaek,et al.  Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells , 1997, Histopathology.

[8]  H. Cooke,et al.  Polymerase chain reaction screening for Y chromosome microdeletions: a first step towards the diagnosis of genetically-determined spermatogenic failure in men. , 1996, Molecular human reproduction.

[9]  A. Edelmann,et al.  Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. , 1996, Human molecular genetics.

[10]  D. Page,et al.  Severe oligozoospermia resulting from deletions of azoospermia factor gene on Y chromosome , 1996, The Lancet.

[11]  N. Skakkebæk,et al.  PROLONGED EXPRESSION OF THE c‐kit RECEPTOR IN GERM CELLS OF INTERSEX FETAL TESTES , 1996, The Journal of pathology.

[12]  S. Rozen,et al.  Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA–binding protein gene , 1995, Nature Genetics.

[13]  R. Moll,et al.  Differentiation potential of ovarian dysgerminoma: an immunohistochemical study of 15 cases. , 1995, Human pathology.

[14]  Howard J. Cooke,et al.  A Y chromosome gene family with RNA-binding protein homology: Candidates for the azoospermia factor AZF controlling human spermatogenesis , 1993, Cell.

[15]  N. Jørgensen,et al.  Immunohistochemical expression of embryonal marker TRA‐1–60 in carcinoma in situ and germ cell tumors of the testis , 1993, Cancer.

[16]  L. Happerfield,et al.  Morphology and immunohistochemistry of carcinoma in situ adjacent to testicular germ cell tumours in adults and children: implications for histogenesis , 1991, Histopathology.

[17]  R. Moll,et al.  Intermediate filament protein profiles of human testicular non-seminomatous germ cell tumors: correlation of cytokeratin synthesis to cell differentiation. , 1991, Differentiation; research in biological diversity.

[18]  A. Giwercman,et al.  Placental‐like alkaline phosphatase as a marker of carcinoma‐in‐situ of the testis. Comparison with monoclonal antibodies M2A and 43–9F , 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[19]  R. Moll,et al.  Heterogeneity of intermediate filament expression in human testicular seminomas. , 1990, Differentiation; research in biological diversity.

[20]  N. Skakkebæk,et al.  A monoclonal antibody as a marker for carcinoma in situ germ cells of the human adult testis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[21]  J. Srigley,et al.  The ultrastructure and histogenesis of male germ neoplasia with emphasis on seminoma with early carcinomatous features. , 1988, Ultrastructural pathology.

[22]  D. Page,et al.  Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. , 1987, Development.

[23]  J. Hustin,et al.  Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours. , 1987, International journal of andrology.